ERIC SCHERBINSKI: Open Payments
NPI 1104374057 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 7 payments from 6 companies in 2025. Trend: 2023 $179 · 2024 $167 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $211 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| ABIOMED | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| BridgeBio Pharma, Inc. | 1 | $14 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, JARDIANCE, ELIQUIS, CARDIOMEMS, LEQVIO, Attruby.
Industry payments across MI — which companies pay providers there.
